Andreas Meisel;Josef Priller;Christel Bonnas;Ulrich Dirnagl
发明人:
Andreas Meisel,Josef Priller,Christel Bonnas,Ulrich Dirnagl
申请号:
US12334995
公开号:
US09988427B2
申请日:
2008.12.15
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The present invention relates to novel endogenous variants of erythropoietin (EPO) and their use for treatment or prevention of a condition associated with tissue damage due to cell death (apoptosis, necrosis) and inflammation, in particular for neuroprotection, e.g. treatment of acute (for example stroke) and chronic disease (for example ALS) of the nervous system.